BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9887214)

  • 1. Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay.
    Klunk WE; Jacob RF; Mason RP
    Anal Biochem; 1999 Jan; 266(1):66-76. PubMed ID: 9887214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pinacyanol as effective probe of fibrillar beta-amyloid peptide: comparative study with Congo Red.
    Sabaté R; Estelrich J
    Biopolymers; 2003; 72(6):455-63. PubMed ID: 14587068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detergent-like interaction of Congo red with the amyloid beta peptide.
    Lendel C; Bolognesi B; Wahlström A; Dobson CM; Gräslund A
    Biochemistry; 2010 Feb; 49(7):1358-60. PubMed ID: 20070125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inflammation-sensitive protein alpha 1-anti-chymotrypsin neutralizes fibrillar aggregation and cytotoxicity of the beta-amyloid peptide more effectively than alpha 1-antitrypsin.
    Giunta S; Galeazzi R; Marcellini M; Corder EH; Galeazzi L
    Clin Biochem; 2007 Aug; 40(12):887-92. PubMed ID: 17512513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid beta (1-42) folding multiplicity and single-molecule binding behavior studied with STM.
    Ma X; Liu L; Mao X; Niu L; Deng K; Wu W; Li Y; Yang Y; Wang C
    J Mol Biol; 2009 May; 388(4):894-901. PubMed ID: 19328210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B binds to amyloid fibrils and delays their formation: a therapeutic mechanism?
    Hartsel SC; Weiland TR
    Biochemistry; 2003 May; 42(20):6228-33. PubMed ID: 12755626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding.
    Milton NG; Harris JR
    Micron; 2009 Dec; 40(8):800-10. PubMed ID: 19683452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid-derived pentapeptide RIIGLa inhibits Abeta(1-42) aggregation and toxicity.
    Fülöp L; Zarándi M; Datki Z; Soós K; Penke B
    Biochem Biophys Res Commun; 2004 Nov; 324(1):64-9. PubMed ID: 15464983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations.
    Wu C; Wang Z; Lei H; Zhang W; Duan Y
    J Am Chem Soc; 2007 Feb; 129(5):1225-32. PubMed ID: 17263405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
    Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
    Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N; Cócera M; Cladera J
    Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.
    Liu D; Xu Y; Feng Y; Liu H; Shen X; Chen K; Ma J; Jiang H
    Biochemistry; 2006 Sep; 45(36):10963-72. PubMed ID: 16953582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A beta fibrillogenesis: kinetic parameters for fibril formation from congo red binding.
    Inouye H; Kirschner DA
    J Struct Biol; 2000 Jun; 130(2-3):123-9. PubMed ID: 10940220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congo red and thioflavin-T analogs detect Abeta oligomers.
    Maezawa I; Hong HS; Liu R; Wu CY; Cheng RH; Kung MP; Kung HF; Lam KS; Oddo S; Laferla FM; Jin LW
    J Neurochem; 2008 Jan; 104(2):457-68. PubMed ID: 17953662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.
    Podlisny MB; Walsh DM; Amarante P; Ostaszewski BL; Stimson ER; Maggio JE; Teplow DB; Selkoe DJ
    Biochemistry; 1998 Mar; 37(11):3602-11. PubMed ID: 9521679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid assembly of amyloid-beta peptide at a liquid/liquid interface produces unstable beta-sheet fibers.
    Nichols MR; Moss MA; Reed DK; Hoh JH; Rosenberry TL
    Biochemistry; 2005 Jan; 44(1):165-73. PubMed ID: 15628857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation.
    Gestwicki JE; Crabtree GR; Graef IA
    Science; 2004 Oct; 306(5697):865-9. PubMed ID: 15514157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.